Literature DB >> 21252203

Insulin resistance and hepatitis C: an evolving story.

Mohammed Eslam1, Mahmoud Aboelneen Khattab, Stephen A Harrison.   

Abstract

Insulin resistance and diabetes are inextricably linked to chronic hepatitis C. Our understanding of this relationship continues to improve. This review focuses on the molecular mechanisms relating insulin resistance to hepatitis C with a subsequent overview of the consequences of hepatitis C-associated insulin resistance and diabetes, as well as perspectives for future management.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21252203     DOI： 10.1136/gut.2010.228262

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  15 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

2.  Peroxisome proliferator-activated receptors and hepatitis C virus.

Authors:  M Eslam; M A Khattab; S A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

3.  Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.

Authors:  Ivan Gentile; Antonio Riccardo Buonomo; Riccardo Scotto; Emanuela Zappulo; Canio Carriero; Mauro Piccirillo; Francesco Izzo; Marianna Rizzo; Dionigio Cerasuolo; Guglielmo Borgia; Ernesta Cavalcanti
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 4.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

Review 5.  Lipids and HCV.

Authors:  M F Bassendine; D A Sheridan; S H Bridge; D J Felmlee; R D G Neely
Journal:  Semin Immunopathol       Date:  2012-10-31       Impact factor: 9.623

Review 6.  Immunologic, metabolic and genetic factors in hepatitis C virus infection.

Authors:  Nora A Fierro; Karina Gonzalez-Aldaco; Rafael Torres-Valadez; Erika Martinez-Lopez; Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.

Authors:  Mohammed Eslam; David R Booth; Jacob George; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

8.  Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.

Authors:  Lin Deng; Ikuo Shoji; Wataru Ogawa; Shusaku Kaneda; Tomoyoshi Soga; Da-peng Jiang; Yoshi-Hiro Ide; Hak Hotta
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

9.  The impact of host factors on management of hepatitis C virus.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

10.  Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody.

Authors:  Chi Hoon Lee; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jung Won Jeon; Jun Uk Lim; Joon Ki Min; Dong Hee Kim; Sung Wook Kang; Hyun Jun Joung
Journal:  Clin Mol Hepatol       Date:  2013-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.